Pharmafile Logo
Pharmafocus logo
Advanced Search
Novartis image

Novartis sales below forecast in ‘transformative’ year

January 28, 2015
Sales and Marketing Diovan, Exforge, Gleevec, Jimenez, Novartis, amlodipine, q4, valsartan

Novartis’ fourth quarter sales have faded slightly as growth in pharmaceuticals is beaten back by generic competition, and the firm …

News
Pfizer image

Pfizer posts fourth-quarter revenue decline

January 28, 2015
Sales and Marketing Eliquis, Lipitor, Lyrica (pregablin), Pfizer, Read, Xeljanz, apixaban, financials, pneumococcal vaccine Prevnar, q4, tofacitinib citrate

Pfizer posted a 3% decline in revenue in the last quarter of 2014, the company’s latest financial results show. The …

News
Soliris image

NICE approves world’s most expensive drug

January 28, 2015
Sales and Marketing Alexion, Dillon, NHS, NICE, aHUS, eculizumab, hst, soliris

The world’s most expensive drug has been approved in final guidance from NICE, making it the first drug to pass …

News
screen_shot_2015-01-28_at_07

New FDA commissioner for medical products named

January 28, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Robert Califf

US Food and Drug Administration commissioner Margaret Hamburg has appointed industry veteran Dr Robert Califf as the FDA’s deputy commissioner …

Appointment
GSK image

GSK denies China job cutting rumours

January 27, 2015
Medical Communications, Research and Development, Sales and Marketing China, GSK, Jobs, Novartis, caixin, pharma

GlaxoSmithKline has told Pharmafile that the news and rumours circulating about 1,000 employees facing the axe in China are not …

News

George Freeman – a US blog

January 27, 2015
Medical Communications, Sales and Marketing ABPI, Cameron, Kaiser Permanente, Obama, george freeman, google, life sciences

It is a privilege to have been appointed as the first ever minister for life sciences.I’m determined to ensure that …

News
Nexium image

Teva’s Nexium copycat approved in US

January 27, 2015
Manufacturing and Production, Sales and Marketing AstraZeneca, Teva, esomeprazole, gerd, heart, nsaids

Teva has won approval for its copycat form of AstraZeneca’s big-selling heatburn drug Nexium, making it the first generic version …

News
Vaccine image

Pharma firms pledge vaccine support for developing countries

January 27, 2015
Manufacturing and Production, Research and Development, Sales and Marketing GAVI, GSK, Janssen, Médecins Sans Frontières, Pfizer, Vaccine

Several pharma firms have announced commitments to help Gavi, the global vaccine alliance, to increase immunisation of children in developing …

News
Bayer image

Bayer launches major new stroke trial

January 27, 2015
Research and Development, Sales and Marketing Bayer, Canadian Stroke Prevention Intervention Network, Population Health Research Institute, Xarelto, rivaroxaban, stroke

Bayer is enrolling more than 7,000 people in a trial to test whether its blood-thinning drug Xarelto can successfully prevent …

News
virginia_acha

ABPI appoints Amgen director to innovation role

January 27, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Amgen, Bina Rawal, Virginia Acha

The Association of the British Pharmaceutical Industry (ABPI) has named Dr Virginia Acha as its new executive director of Research …

Appointment
Actavis image

Actavis buys generics firm for £306 million

January 26, 2015
Manufacturing and Production, Sales and Marketing Actavis, Allergan, Auden McKenzie, generics

Actavis is buying UK-based development and marketing firm Auden McKenzie in a deal worth up to £306 million. The move …

News
Gilead image

New drug added to generic Sovaldi licensing

January 26, 2015
Manufacturing and Production, Sales and Marketing Gilead, HCV, hepatitis C, sofosbuvir, sovaldi

Gilead has expanded the licensing of generic versions of its blockbuster hepatitis C treatment Sovaldi to include a new experimental …

News
Shire image

Shire lifted by rare disease approvals

January 26, 2015
Sales and Marketing HGT-2310, Hunter syndrome, SHP609, Shire, fast track, idursulfase-IT, rare disease

Shire’s investigational drug for a rare neurological disease has been accepted into the FDA’s fast-track approval process. The drug, SHP609, …

News
Xarelto image

NICE recommends Bayer heart attack drug

January 26, 2015
Sales and Marketing ACS, Bayer, J&J, JJ, NICE, Xarelto, q4, rivaroxaban

NICE has recommended Xarelto in final draft guidance as an option for preventing blood clots in people who have had …

News
Novartis image

Novartis earns EMA and FDA nods for Jakavi and Bexsero

January 26, 2015
Sales and Marketing Bexsero, Cancer, EU, FDA, Jakavi, Novartis, US, meningitis, ruxolitinib

Novartis has secured the regulatory go-ahead for two of its drugs, after the EMA recommended Jakavi for a rare blood …

News
screen_shot_2015-01-26_at_07

Working Life: NHS England pharma officer Dr Bruce Warner

January 26, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS England, Working Life, bruce warner, pharma officer

 How did you find your way into your current role? I have had a very eclectic career for a pharmacist …

Feature
lynne_bulger

Cipher appoints vice president and promotes two

January 26, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Linda Angaritis, Peter Weiler, cipher, lynne bulgar

Cipher Pharmaceuticals has appointed Lynne Bulger as vice president of its medical and clinical affairs whilst also promoting Peter Weiler …

Appointment
GSK image

GSK launches Ebola Phase III trial in Liberia

January 23, 2015
Research and Development, Sales and Marketing Africa, Ebola, GSK, US National Institutes of Health, WHO, Wellcome Trust, liberia, newlink

A shipment of GSK’s potential vaccine against the Ebola virus disease is on its way to Liberia ready to be …

News
Tattoo image

Needle-free device shows potential in diabetes

January 23, 2015
Medical Communications, Sales and Marketing Cygnus, University of California, diabetes, tattoo

A ‘tattoo-like’ ultra-thin sensor that sits on the skin has been developed that could help patients monitor their blood glucose …

News
gad_berdugo_

Immune Pharmaceuticals appoints three

January 23, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Immune Pharmaceuticals, cameron durrant, elliot maza, gad berdugo

US antibody development firm Immune Pharmaceuticals has appointed Gad Berdugo (pictured) as its executive VP and chief financial officer, and …

Appointment
The Gateway to Local Adoption Series

Latest content

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026